Quick Answer
Vicapsys Life Sciences, Inc. reported Net Income Loss of -$1.18 million for the year ending 2023.
- Vicapsys Life Sciences, Inc. showed a decrease of -20.0% in Net Income Loss from 2022 to 2023.
- This data is from Vicapsys Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on October 21, 2024.
- XBRL data for this metric is available from 2019 to 2023 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2019 to 2023), Vicapsys Life Sciences, Inc.'s Net Income Loss has grown by 16.1%.
- Historical annual values: Fiscal year 2023: -$1.18 million | Fiscal year 2022: -$984.8 thousand | Fiscal year 2021: -$236.9 thousand | Fiscal year 2020: -$765.8 thousand | Fiscal year 2019: -$1.41 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: